Accessibility Menu
 
Charles River Laboratories International logo

Charles River Laboratories International

(NYSE) CRL

Current Price$166.46
Market Cap$8.45B
Since IPO (2000)+678%
5 Year-49%
1 Year+49%
1 Month+8%

Charles River Laboratories International Financials at a Glance

Market Cap

$8.45B

Revenue (TTM)

$4.02B

Net Income (TTM)

$144.34M

EPS (TTM)

$-2.96

P/E Ratio

-57.92

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Price

$166.46

Volume

633,271

Open

$170.42

Previous Close

$166.79

Daily Range

$165.07 - $170.95

52-Week Range

$113.89 - $228.88

CRL: Motley Fool Moneyball Superscore

57

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Charles River Laboratories International

Industry

Life Sciences Tools and Services

Employees

19,700

CEO

James C. Foster

Headquarters

Wilmington, MA 01887, US

CRL Financials

Key Financial Metrics (TTM)

Gross Margin

33%

Operating Margin

11%

Net Income Margin

-4%

Return on Equity

-4%

Return on Capital

7%

Return on Assets

-2%

Earnings Yield

-1.73%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.45B

Shares Outstanding

49.34M

Volume

633.27K

Avg. Volume

1.01M

Financials (TTM)

Gross Profit

$1.23B

Operating Income

$507.84M

EBITDA

$911.15M

Operating Cash Flow

$737.65M

Capital Expenditure

$219.15M

Free Cash Flow

$518.49M

Cash & ST Invst.

$213.77M

Total Debt

$3.07B

Charles River Laboratories International Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$994.23M

-0.8%

Gross Profit

$307.86M

+8.3%

Gross Margin

30.96%

N/A

Market Cap

$8.45B

N/A

Market Cap/Employee

$451.81K

N/A

Employees

18,700

N/A

Net Income

$276.56M

-28.2%

EBITDA

$198.50M

+329.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.85B

-12.7%

Accounts Receivable

$708.86M

-1.7%

Inventory

$299.10M

+7.4%

Long Term Debt

$3.00B

+10.3%

Short Term Debt

$61.06M

N/A

Return on Assets

-2.02%

N/A

Return on Invested Capital

7.13%

N/A

Free Cash Flow

$58.57M

-30.1%

Operating Cash Flow

$147.52M

-7.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BAXBaxter International Inc.
$17.94-2.97%
BIOBio-Rad Laboratories, Inc.
$279.34-2.77%
RVTYRevvity, Inc.
$85.18-1.87%
QGENQiagen N.V.
$34.02-10.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$213.17-0.02%
POETPoet Technologies
$8.03+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$60.74-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.14-0.01%

Questions About CRL

What is the current price of Charles River Laboratories International?

Charles River Laboratories International is trading at $166.79 per share.

What is the 52-week range for Charles River Laboratories International?

Over the past 52 weeks, Charles River Laboratories International has traded between $113.89 and $228.88.

How much debt does Charles River Laboratories International have?

As of the most recent reporting period, Charles River Laboratories International reported total debt of $2.63B.

How much cash does Charles River Laboratories International have on hand?

Charles River Laboratories International reported $214.44M in cash and cash equivalents in its most recent financial results.

What is Charles River Laboratories International’s dividend yield?

Charles River Laboratories International does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.